28(top 2%)
papers
886(top 2%)
citations
15(top 2%)
h-index
21(top 2%)
g-index
28
all documents
1.0K
doc citations
432
citing journals

Top Articles

#TitleJournalYearCitations
1Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working groupModern Pathology2016230
2Principles Governing A-to-I RNA Editing in the Breast Cancer TranscriptomeCell Reports2015179
3DNA methylation–based immune response signature improves patient diagnosis in multiple cancersJournal of Clinical Investigation2017110
4The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapyESMO Open202095
5Immunity drives TET1 regulation in cancer through NF-κBScience Advances201864
6Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?Translational Oncology202046
7Adjuvant trastuzumab: a 10-year overview of its benefitExpert Review of Anticancer Therapy201740
8Breast cancer vaccines: Heeding the lessons of the past to guide a path forwardCancer Treatment Reviews202035
9Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune SuppressionMolecular Diagnosis and Therapy202133
10A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of ExperienceBiopreservation and Biobanking201629
11Radiomics and “radi-…omics” in cancer immunotherapy: a guide for cliniciansCritical Reviews in Oncology/Hematology202026
12Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature ReviewTargeted Oncology202025
13Targeting CTLA‐4 in cancer: Is it the ideal companion for PD‐1 blockade immunotherapy combinations?International Journal of Cancer202123
14Tumor-Derived Thymic Stromal Lymphopoietin Expands Bone Marrow B-cell Precursors in Circulation to Support MetastasisCancer Research201921
15Targeting PD-1 in cancer: Biological insights with a focus on breast cancerCritical Reviews in Oncology/Hematology201918
16A review of immune checkpoint blockade in breast cancerSeminars in Oncology202111
17Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung CancerFrontiers in Oncology20208
18Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New ResearchTargeted Oncology20223
19Tumor infiltrating lymphocytes in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of published randomized clinical trialsAnnals of Oncology20172
20Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockadeActa Clinica Belgica20212
21Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trialAnnals of Oncology20171
22The Composition and Organization of Lymphocytes Infiltrating Human Breast CancerAnnals of Oncology20130
23Immunology of Solid Tumors Beyond Tumor-Infiltrating Lymphocytes: The Role of Tertiary Lymphoid Structures20170
24FOXP1 suppresses chemokine genes critical for TIL migration and function in breast tumorsAnnals of Oncology20170
25The dynamics between neo-adjuvant treatment and immune responses in human breast cancerAnnals of Oncology20190
26FOXP1, PD-1 AND PD-L1 ARE SIGNIFICANTLY UPREGULATED IN LYMPHOCYTES FROM CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMPARED TO AGE-MATCHED HEALTHY DONORSHematological Oncology20190
27Transcription Factors and Checkpoint Inhibitor Expression with Age: Markers of Immunosenescence?Blood20160
28Multiplex IHC panel development for adenosine pathway markers and TIL in human cancer specimensAnnals of Oncology20190